ASCENT THERAPEUTICS

Ascent Therapeutics is pioneering a new class of drugs called pepducins. Pepducins are a breakthrough approach to targeting G-protein coupled receptors (GPCRs) on the inside surface of the cell membrane, dramatically expanding the GPCR frontier. GPCRs are critically involved in a wide variety of serious illnesses, including inflammation, cancer, metabolic CNS disorders and cardiovascular disease. Pepducin technology represents an exciting new area of research directed towards a well-validated class of drug targets.

#Financial #Website #More

ASCENT THERAPEUTICS

Industry:

Biotechnology Health Care Medical

Founded:

2006-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.ascentrx.com

Total Employee:

1+

Status:

Active

Contact:

617-715-1999

Email Addresses:

[email protected]

Total Funding:

19 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains

Investors List

healthcare-ventures_image

HealthCare Ventures

HealthCare Ventures investment in Series A - Ascent Therapeutics

tvm-capital_image

TVM Capital

TVM Capital investment in Series A - Ascent Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series A - Ascent Therapeutics

Official Site Inspections

http://www.ascentrx.com

Host Informations
Whois Informations

Loading ...

More informations about "Ascent Therapeutics" on Search Engine